Clinical Applications of Molecular Imaging in the Management of Prostate Cancer

Michael A. Gorin; Steven P. Rowe; Samuel R. Denmeade

doi:10.1016/j.cpet.2016.11.001

Clinical Applications of Molecular Imaging in the Management of Prostate Cancer

Michael A. Gorin, Steven P. Rowe, Samuel R. Denmeade

School of Medicine

Research output: Contribution to journal › Review article › peer-review

9 Scopus citations

Abstract

At the heart of selecting an optimal management strategy for men with prostate cancer is accurately determining a given patient's clinical stage and extent of disease. Molecular imaging with PET using properly selected radiotracers offers the opportunity for improved contrast resolution over conventional imaging and thus increased sensativity for detecting sites of disease. In addition, molecular imaging provides the prospect of obtaining functional or biological information regarding a patient's cancer. To date, several PET radiotracers have been developed for prostate cancer imaging. This review summarizes the potential clinical applications of molecular imaging in the management of men with prostate cancer.

Original language	English (US)
Pages (from-to)	185-192
Number of pages	8
Journal	PET Clinics
Volume	12
Issue number	2
DOIs	https://doi.org/10.1016/j.cpet.2016.11.001
State	Published - Apr 1 2017

Keywords

Cancer staging
Molecular imaging
PET
Prostate cancer

ASJC Scopus subject areas

Radiation
Radiology Nuclear Medicine and imaging

Access to Document

10.1016/j.cpet.2016.11.001

Cite this

@article{41be2f96700b4df4905fd97355b3190e,

title = "Clinical Applications of Molecular Imaging in the Management of Prostate Cancer",

abstract = "At the heart of selecting an optimal management strategy for men with prostate cancer is accurately determining a given patient's clinical stage and extent of disease. Molecular imaging with PET using properly selected radiotracers offers the opportunity for improved contrast resolution over conventional imaging and thus increased sensativity for detecting sites of disease. In addition, molecular imaging provides the prospect of obtaining functional or biological information regarding a patient's cancer. To date, several PET radiotracers have been developed for prostate cancer imaging. This review summarizes the potential clinical applications of molecular imaging in the management of men with prostate cancer.",

keywords = "Cancer staging, Molecular imaging, PET, Prostate cancer",

author = "Gorin, {Michael A.} and Rowe, {Steven P.} and Denmeade, {Samuel R.}",

note = "Publisher Copyright: {\textcopyright} 2016 Elsevier Inc.",

year = "2017",

month = apr,

day = "1",

doi = "10.1016/j.cpet.2016.11.001",

language = "English (US)",

volume = "12",

pages = "185--192",

journal = "PET Clinics",

issn = "1556-8598",

publisher = "W.B. Saunders Ltd",

number = "2",

}

TY - JOUR

T1 - Clinical Applications of Molecular Imaging in the Management of Prostate Cancer

AU - Gorin, Michael A.

AU - Rowe, Steven P.

AU - Denmeade, Samuel R.

PY - 2017/4/1

Y1 - 2017/4/1

N2 - At the heart of selecting an optimal management strategy for men with prostate cancer is accurately determining a given patient's clinical stage and extent of disease. Molecular imaging with PET using properly selected radiotracers offers the opportunity for improved contrast resolution over conventional imaging and thus increased sensativity for detecting sites of disease. In addition, molecular imaging provides the prospect of obtaining functional or biological information regarding a patient's cancer. To date, several PET radiotracers have been developed for prostate cancer imaging. This review summarizes the potential clinical applications of molecular imaging in the management of men with prostate cancer.

AB - At the heart of selecting an optimal management strategy for men with prostate cancer is accurately determining a given patient's clinical stage and extent of disease. Molecular imaging with PET using properly selected radiotracers offers the opportunity for improved contrast resolution over conventional imaging and thus increased sensativity for detecting sites of disease. In addition, molecular imaging provides the prospect of obtaining functional or biological information regarding a patient's cancer. To date, several PET radiotracers have been developed for prostate cancer imaging. This review summarizes the potential clinical applications of molecular imaging in the management of men with prostate cancer.

KW - Cancer staging

KW - Molecular imaging

KW - PET

KW - Prostate cancer

UR - http://www.scopus.com/inward/record.url?scp=85009343063&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85009343063&partnerID=8YFLogxK

U2 - 10.1016/j.cpet.2016.11.001

DO - 10.1016/j.cpet.2016.11.001

M3 - Review article

C2 - 28267452

AN - SCOPUS:85009343063

SN - 1556-8598

VL - 12

SP - 185

EP - 192

JO - PET Clinics

JF - PET Clinics

IS - 2

ER -

Clinical Applications of Molecular Imaging in the Management of Prostate Cancer

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this